title: Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions.
abstract: Percutaneous coronary intervention (PCI) decreases ischemic complications of acute coronary syndromes. The benefits of PCI in stable ischemic heart disease (SIHD) depend on its effect on quality of life (QoL), including angina, physical activity, and emotional well-being. PCI decreases angina and the need for anti-anginal medications, and increases exercise capacity and QoL, compared with baseline status and compared with medical therapy without PCI. These benefits are greater when QOL is markedly impaired by severe angina before the procedure. When considering treatment options for symptomatic SIHD, physicians should consider and provide objective data regarding QoL effects for each treatment strategy. QoL outcomes should be considered in clinical trials, appropriate use criteria, practice guidelines, and reimbursement policies for PCI.
authors.forename: James C
authors.initials: JC
authors.lastname: Blankenship
authors.forename: J Jeffrey
authors.initials: JJ
authors.lastname: Marshall
authors.forename: Duane S
authors.initials: DS
authors.lastname: Pinto
authors.forename: Richard A
authors.initials: RA
authors.lastname: Lange
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Holper
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
authors.forename: Charles E
authors.initials: CE
authors.lastname: Chambers
mesh_terms: D000787:Angina Pectoris / Q000523:psychology / Q000628:therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004644:Emotions; D017079:Exercise Tolerance; D006304:Health Status; D006801:Humans; D008603:Mental Health; D017202:Myocardial Ischemia / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D018579:Patient Selection; D062645:Percutaneous Coronary Intervention / Q000592:standards*; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents